2BMonthly

Executives share insight on what aspects of ag technology they see as having the greatest impact on the growth in biologicals.

From formulation to manufacturing, experts share their insight on where we can expect the industry’s greatest innovations.

Executives offer their views on investment expectations for biologicals in the short to medium term.

Executives share insight on what product categories they anticipate will drive the most growth in the next 10 years in biologicals.

Biological executives share whether they have felt any impact from the regulatory slowdown stemming from the U.S. Endangered Species Act.